NCT04167150

Brief Summary

In spite of aggressive approaches to prevent and treat osteoporosis, it remains one of the most costly and debilitating diseases associated with aging. The pursuit of alternative approaches for preventing bone loss has included the investigation of a number of promising plant-based foods that can be incorporated into the diet. This project is an extension of our pre-clinical studies with tart cherry, designed to determine whether the findings from our animal study can be extended to humans. Thus, the purpose of this project is to investigate the dose-dependent effect of tart cherry juice consumption on biomarkers of bone metabolism in women, aged 65-80 years. The hypothesis to be tested is that three months of tart cherry supplementation will improve bone biomarkers in a dose-dependent manner. Moreover, these improvements in bone metabolism will correspond to a decrease in markers of inflammation and oxidative stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 6, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 10, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
Last Updated

November 18, 2019

Status Verified

November 1, 2019

Enrollment Period

12 months

First QC Date

November 10, 2019

Last Update Submit

November 15, 2019

Conditions

Keywords

osteoporosisbiomarkerstart cherryfunctional food

Outcome Measures

Primary Outcomes (2)

  • Bone-specific alkaline phosphatase (U/L)

    Bone formation marker

    Change from baseline to final visits (3 month intervention)

  • Tartrate resistant acid phosphatase (U/L)

    Bone resorption marker

    Change from baseline to final visits (3 month intervention)

Secondary Outcomes (2)

  • C-reactive protein (mg/L)

    Change from baseline to final visits (3 month intervention)

  • Thiobarbituric acid reactive species (TBARS) (U/L)

    Change from baseline to final visits (3 month intervention)

Study Arms (2)

Dose 1

ACTIVE COMPARATOR

Participants consume 8 fl oz of tart cherry juice per day.

Dietary Supplement: tart cherry juice concentrate is a commercial product provided by King Orchards (Central Lake, MI)

Dose 2

EXPERIMENTAL

Participants consume 2 x 8 fl oz of tart cherry juice per day.

Dietary Supplement: tart cherry juice concentrate is a commercial product provided by King Orchards (Central Lake, MI)

Interventions

Participants were instructed to reconstitute the tart cherry juice concentrate in 8 fl oz of water and consume either 1x or 2x daily for 3 months.

Dose 1Dose 2

Eligibility Criteria

Age65 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Women, 65-80 years of age
  • Capacity to give informed consent

You may not qualify if:

  • Hormone replacement therapy in the 3 months prior to starting the study
  • Bisphosphonates in the 3 months prior to starting the study
  • Raloxifene in the 3 months prior to starting the study
  • Intermittent parathyroid hormone in the 3 months prior to starting the study
  • Growth hormone or steroids in the 3 months prior to starting the study
  • Osteoporosis
  • Renal disease
  • Cancer
  • Cardiovascular disease
  • Diabetes
  • Respiratory disease
  • Gastrointestinal diseases
  • Liver disease
  • Other chronic conditions that could affect bone metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma State University - Nutritional Sciences

Stillwater, Oklahoma, 74078, United States

Location

MeSH Terms

Conditions

Osteoporosis, PostmenopausalOsteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized dose-response pre-test, post-test study design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Nutrition

Study Record Dates

First Submitted

November 10, 2019

First Posted

November 18, 2019

Study Start

June 6, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

November 18, 2019

Record last verified: 2019-11

Locations